SHAB published 3 Jun 2026 · legal date 19 May 2026
Capital increase
●●○Likely financing
Paid in cash
Nominal capital
150’000 → 190’750
Shares
3’000’000 → 3’815’000
New shares, % of post-step shares
21.4% (815’000 new)
Aktienkapital neu: CHF 190'750.00 [bisher: CHF 150'000.00]. Liberierung Aktienkapital neu: CHF 190'750.00 [bisher: CHF 150'000.00]. Aktien neu: 3'815'000 Namenaktien zu CHF 0.05 [bisher: 3'000'000 Namenaktien zu CHF 0.05]. [gestrichen: Die Gesellschaft hat mit Beschluss vom 08.06.2020 eine genehmigte Kapitalerhöhung gemäss näherer Umschreibung in den Statuten beschlossen.]. Ordentliche Kapitalerhöhung.
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.82 · likely-financing threshold 0.60 · not a calibrated probability